Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 14, 2005 - Issue 3
Submit an article Journal homepage
159
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluation

Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome

Steven M Donn Department of Pediatrics, Division of Neonatal-Perinatal Medicine, F5790 C.S. Mott Children’s Hospital, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0254, USA. [email protected]
Pages 329-334 | Published online: 22 Apr 2005

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Brian K Jordan & Steven M Donn. (2013) Lucinactant for the prevention of respiratory distress syndrome in premature infants. Expert Review of Clinical Pharmacology 6:2, pages 115-121.
Read now
Steven M Donn & Sunil K Sinha. (2008) Aerosolized lucinactant: a potential alternative to intratracheal surfactant replacement therapy. Expert Opinion on Pharmacotherapy 9:3, pages 475-478.
Read now

Articles from other publishers (9)

Lei Wang, Nanxi Wang, Zhibin Yan, Zhifeng Huang & Caiyun Fu. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery 795 815 .
Aneta M Białkowska, Krzysztof Morawski & Tomasz Florczak. (2017) Extremophilic proteases as novel and efficient tools in short peptide synthesis. Journal of Industrial Microbiology and Biotechnology 44:9, pages 1325-1342.
Crossref
Kazumichi Fujioka, Flora Kalish, Ronald J. Wong & David K. Stevenson. (2015) Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model. Pediatric Research 79:2, pages 251-257.
Crossref
Jennifer M. Belavic. (2013) Drug updates and approvals. The Nurse Practitioner 38:2, pages 24-42.
Crossref
Mithilesh K LalSunil K Sinha. (2009) Lucinactant (Surfaxin™) for prevention and treatment of respiratory distress syndrome in newborns. Pediatric Health 3:5, pages 427-434.
Crossref
Anita Bhandari & Vineet Bhandari. (2009) Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia. Pediatrics 123:6, pages 1562-1573.
Crossref
Matthew Laughon, Carl Bose, Fernando Moya, Judy Aschner, Steven Mark Donn, Christopher Morabito, James John Cummings, Robert Segal, Carlos Guardia & Genzhou Liu. (2009) A Pilot Randomized, Controlled Trial of Later Treatment With a Peptide-Containing, Synthetic Surfactant for the Prevention of Bronchopulmonary Dysplasia. Pediatrics 123:1, pages 89-96.
Crossref
Th. Lacaze-Masmonteil. (2008) Une nouvelle génération de surfactants de synthèse. Archives de Pédiatrie 15, pages S42-S46.
Crossref
Sunil Sinha, Fernando Moya & Steven M Donn. (2007) Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?. Current Opinion in Pediatrics 19:2, pages 150-154.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.